Register for the Beta

Can Vitamins Actually Make You Less Healthy? The Trials That Changed Supplement Science

Vitamins & Longevity Research Article 5 of 8

Vitamin E increased prostate-cancer risk in SELECT. Beta-carotene plus retinol increased lung cancer and mortality in high-risk CARET participants. 'Antioxidant' never meant 'risk-free'.

Authors
Thomas Byman & Tobias Byman TwinPare Research
Category
Research / Vitamins, Supplements & Longevity
Language
English
Status
Published
Source status
Sources reviewed for publication
Last reviewed
2026-09-21
Reading time
7 min read
Twin research on vitamins, supplements & longevity and the interaction between genes, environment and lived health.

For years, antioxidants sounded almost definitionally healthy. If oxidation damages cells, more antioxidants should help — right?

Large randomized trials taught medicine a harder lesson: biology is not a slogan.

Quick answer

Can high-dose vitamin supplements cause harm?

Yes, in specific populations and doses. SELECT and CARET are strong randomized examples showing that plausible antioxidant biology can translate into unexpected harm.

Key takeaways

  • In SELECT, the tested vitamin E regimen increased prostate-cancer incidence in healthy men.
  • In CARET, beta-carotene plus retinol increased lung cancer and total mortality in smokers/asbestos-exposed participants.
  • These findings concern specific doses and populations.
  • They do not mean ordinary foods containing vitamin E or beta-carotene are harmful.

Randomization beats intuition

Observational studies and plausible mechanisms can make an intervention look promising. Randomized trials test what actually happens when people take it.

SELECT and CARET are classic examples of why that distinction matters.

Dose changes the biology

Nutrients from food arrive in complex mixtures and physiological amounts. High-dose isolated supplements can create very different exposure.

That is why 'vitamin' is not a sufficient safety label.

A safer evidence mindset

Ask what population, what dose, what outcome and what baseline nutrient status a trial actually studied.

That four-part question protects readers from both supplement hype and blanket anti-supplement claims.

Source notes

The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.

  1. [select-2011] Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Eric A. Klein et al.. JAMA, 2011. Evidence type: Large randomized placebo-controlled trial in healthy men Limitation: Vitamin E at the tested dose increased prostate-cancer incidence. The result does not imply that all vitamin E from food is harmful. PubMed DOI
  2. [caret-1996] Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial CARET investigators. Journal of the National Cancer Institute, 1996. Evidence type: Large randomized trial in smokers, former smokers and asbestos-exposed participants Limitation: High-dose beta-carotene plus retinol increased lung cancer and total mortality in this high-risk population; food sources and ordinary dietary intake are not equivalent to the tested regimen. PubMed
  3. [nnr-2023] Nordic Nutrition Recommendations 2023 — Dietary supplements Nordic Council of Ministers. Nordic Nutrition Recommendations, 2023. Evidence type: Official Nordic evidence-based nutrition guidance Limitation: NNR states that prolonged supplement use in healthy people with a varied adequate diet has generally not shown chronic-disease benefit, while high intakes of some supplements may cause harm; specific groups can have justified supplementation needs. PubMed
Editorial source review

This section shows how the article's key factual claims are linked to the source.

Phrasings that require caution

  • Do not tell users to stop medically indicated supplements.
  • Do not generalize high-dose trial harm to food intake.
IDClaimSource supportCaution